Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $108.65 USD
Change Today +1.11 / 1.03%
Volume 5.5M
CELG On Other Exchanges
Symbol
Exchange
Frankfurt
NASDAQ GM
As of 4:30 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Hugin MBA

Chairman, Chief Executive Officer and Chairman of Executive Committee, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 32 board members in 4 different organizations across 4 different industries.

See Board Relationships
59$24,236,113
As of Fiscal Year 2014

Background*

Mr. Robert J. Hugin, also known as Bob, MBA has been the Chief Executive Officer of Celgene Corporation since June 16, 2010. Mr. Hugin served as the President of Celgene Corporation since May 1, 2006 until August 1, 2014. He served as Secretary of Celgene Corporation and served as its Chief Financial Officer from June 1999 to May 1, 2006, Chief Operating Officer from May 1, 2006 to June 16, 2010 and as its Senior Vice President from June 1999 to May 1, 2006. At Celgene ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: --

Board Members Memberships*

Director
2001-Present
Chairman, Chief Executive Officer and Chairman of Executive Committee
2003-Present
Independent Director and Chairman of Audit Committee
2005-Present
Director and Member of Audit Committee

Education*

BA 1976
Princeton University
MBA 1985
University of Virginia

Other Affiliations*

Annual Compensation*

Salary$1,380,000
Total Annual Compensation$1,380,000

Stock Options*

Restricted Stock Awards$3,899,980
All Other Compensation$231,416
Exercised Options934,808
Exercised Options Value$81,182,157
Exercisable Options1,474,372
Unexercisable Options970,128
Total Value of Options$81,182,157
Total Number of Options3,379,308

Total Compensation*

Total Annual Cash Compensation$10,721,685
Total Short Term Compensation$1,380,000
Other Long Term Compensation$4,131,396
Total Calculated Compensation$24,236,113
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $108.65 USD +1.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.4M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
$1.2M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.